Legend Biotech (LEGN) shares were down 4.6% in Friday trading after UBS downgraded the company's stock to neutral from buy and adjusted its price target to $28 from $49.

Trading volume stood at over 984,600 shares compared with a daily average of 2.6 million.

Price: 22.45, Change: -1.08, Percent Change: -4.59